{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T01:37:09Z","timestamp":1792719429709,"version":"4.5.0"},"reference-count":88,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cardiovascular Revascularization Medicine"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.carrev.2020.03.030","type":"journal-article","created":{"date-parts":[[2020,3,27]],"date-time":"2020-03-27T11:16:57Z","timestamp":1585307817000},"page":"1276-1284","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Comparative 12-Month Outcomes of Drug-Coated Balloon Versus Non-Drug-Coated Balloon Revascularization Strategy in Chronic Limb-Threatening Ischemia: Results From the XLPAD Registry"],"prefix":"10.1016","volume":"21","author":[{"given":"Stefanos","family":"Giannopoulos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haekyung","family":"Jeon-Slaughter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravi S.","family":"Kahlon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ishita","family":"Tejani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amutha","family":"Baskar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subhash","family":"Banerjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ehrin J.","family":"Armstrong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.carrev.2020.03.030_bb0005","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1161\/CIRCULATIONAHA.110.003954","article-title":"Secondary prevention and mortality in peripheral artery disease: National Health and nutrition examination study, 1999 to 2004","volume":"124","author":"Pande","year":"2011","journal-title":"Circulation."},{"issue":"9901","key":"10.1016\/j.carrev.2020.03.030_bb0010","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/S0140-6736(13)61249-0","article-title":"Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis","volume":"382","author":"Fowkes","year":"2013","journal-title":"Lancet."},{"issue":"Suppl S","key":"10.1016\/j.carrev.2020.03.030_bb0015","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1016\/j.jvs.2006.12.037","article-title":"Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II)","volume":"45","author":"Norgren","year":"2007","journal-title":"Journal of vascular surgery"},{"key":"10.1016\/j.carrev.2020.03.030_bb0020","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.tcm.2019.04.002","article-title":"Lower extremity critical limb ischemia: a review of clinical features and management","volume":"30","author":"Levin","year":"2020","journal-title":"Trends Cardiovasc Med"},{"issue":"3","key":"10.1016\/j.carrev.2020.03.030_bb0025","first-page":"275","article-title":"Treatment of diabetic foot ulcers","volume":"50","author":"Vuorisalo","year":"2009","journal-title":"J Cardiovasc Surg (Torino)"},{"issue":"7389","key":"10.1016\/j.carrev.2020.03.030_bb0030","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1136\/bmj.326.7389.584","article-title":"Management of peripheral arterial disease in primary care","volume":"326","author":"Burns","year":"2003","journal-title":"BMJ (Clinical research ed)"},{"issue":"Suppl. 2","key":"10.1016\/j.carrev.2020.03.030_bb0035","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1016\/S1078-5884(11)60009-9","article-title":"Chapter I: definitions, epidemiology, clinical presentation and prognosis","volume":"42","author":"Becker","year":"2011","journal-title":"European journal of vascular and endovascular surgery: the official journal of the European Society for Vascular Surgery."},{"issue":"4","key":"10.1016\/j.carrev.2020.03.030_bb0040","doi-asserted-by":"crossref","first-page":"343","DOI":"10.3400\/avd.tasc.15-01000","volume":"8","author":"Jaff","year":"2015","journal-title":"Ann Vasc Dis"},{"issue":"22","key":"10.1016\/j.carrev.2020.03.030_bb0045","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1093\/eurheartj\/ehr211","volume":"32","author":"Tendera","year":"2011","journal-title":"Eur Heart J"},{"issue":"4","key":"10.1016\/j.carrev.2020.03.030_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.jvs.2011.03.281","article-title":"Trends in the national outcomes and costs for claudication and limb threatening ischemia: angioplasty vs bypass graft","volume":"54","author":"Sachs","year":"2011","journal-title":"Journal of vascular surgery"},{"issue":"2","key":"10.1016\/j.carrev.2020.03.030_bb0055","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.jvs.2015.03.043","article-title":"The Society for Vascular Surgery\u2019s objective performance goals for lower extremity revascularization are not generalizable to many open surgical bypass patients encountered in contemporary surgical practice","volume":"62","author":"Saraidaridis","year":"2015","journal-title":"J Vasc Surg"},{"issue":"1","key":"10.1016\/j.carrev.2020.03.030_bb0060","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0741-5214(97)70318-5","article-title":"Impact of arterial surgery and balloon angioplasty on amputation: a population-based study of 1155 procedures between 1973 and 1992","volume":"25","author":"Hallett","year":"1997","journal-title":"J Vasc Surg"},{"issue":"1","key":"10.1016\/j.carrev.2020.03.030_bb0065","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0741-5214(03)00092-2","article-title":"Functional outcome in a contemporary series of major lower extremity amputations","volume":"38","author":"Nehler","year":"2003","journal-title":"J Vasc Surg"},{"issue":"1","key":"10.1016\/j.carrev.2020.03.030_bb0070","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.jvs.2009.01.035","article-title":"National trends in lower extremity bypass surgery, endovascular interventions, and major amputations","volume":"50","author":"Goodney","year":"2009","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.carrev.2020.03.030_bb0075","first-page":"Cd002000","article-title":"Bypass surgery for chronic lower limb ischaemia","volume":"4","author":"Antoniou","year":"2017","journal-title":"Cochrane Database Syst Rev."},{"issue":"5","key":"10.1016\/j.carrev.2020.03.030_bb0080","doi-asserted-by":"crossref","first-page":"365","DOI":"10.23736\/S0392-9590.18.03957-3","article-title":"Midterm results with drug-coated balloons for SFA lesions in patients with CLI: comparison with conventional bypass surgery","volume":"37","author":"Goksel","year":"2018","journal-title":"International angiology: a journal of the International Union of Angiology"},{"issue":"3","key":"10.1016\/j.carrev.2020.03.030_bb0085","doi-asserted-by":"crossref","first-page":"NP1","DOI":"10.1177\/1358863X17701592","article-title":"2016 AHA\/ACC guideline on the Management of Patients with lower extremity peripheral artery disease: executive summary","volume":"22","author":"Writing Committee","year":"2017","journal-title":"Vasc Med"},{"issue":"6","key":"10.1016\/j.carrev.2020.03.030_bb0090","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1177\/1526602816671740","volume":"23","author":"Katsanos","year":"2016","journal-title":"Journal of endovascular therapy: an official journal of the International Society of Endovascular Specialists."},{"issue":"24","key":"10.1016\/j.carrev.2020.03.030_bb0095","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1016\/j.jacc.2013.03.034","article-title":"Sustained safety and effectiveness of paclitaxel-eluting stents for femoropopliteal lesions: 2-year follow-up from the Zilver PTX randomized and single-arm clinical studies","volume":"61","author":"Dake","year":"2013","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.carrev.2020.03.030_bb0100","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1056\/NEJMoa1406235","article-title":"Trial of a paclitaxel-coated balloon for Femoropopliteal artery disease","volume":"373","author":"Rosenfield","year":"2015","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.carrev.2020.03.030_bb0105","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1161\/CIRCINTERVENTIONS.112.969972","article-title":"Paclitaxel-coated versus uncoated balloon angioplasty reduces target lesion revascularization in patients with femoropopliteal arterial disease: a meta-analysis of randomized trials","volume":"5","author":"Cassese","year":"2012","journal-title":"Circ Cardiovasc Interv"},{"issue":"5","key":"10.1016\/j.carrev.2020.03.030_bb0110","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1161\/CIRCINTERVENTIONS.111.962324","article-title":"Paclitaxel-eluting stents show superiority to balloon angioplasty and bare metal stents in femoropopliteal disease: twelve-month Zilver PTX randomized study results","volume":"4","author":"Dake","year":"2011","journal-title":"Circ Cardiovasc Interv"},{"issue":"16","key":"10.1016\/j.carrev.2020.03.030_bb0115","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1016\/j.jcin.2016.06.008","article-title":"Drug-coated balloon versus plain balloon angioplasty for the treatment of Femoropopliteal artery disease: an updated systematic review and meta-analysis of randomized clinical trials","volume":"9","author":"Giacoppo","year":"2016","journal-title":"JACC Cardiovasc Interv"},{"issue":"4","key":"10.1016\/j.carrev.2020.03.030_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.jvs.2014.01.041","article-title":"Bayesian network meta-analysis of nitinol stents, covered stents, drug-eluting stents, and drug-coated balloons in the femoropopliteal artery","volume":"59","author":"Katsanos","year":"2014","journal-title":"Journal of vascular surgery"},{"issue":"1","key":"10.1016\/j.carrev.2020.03.030_bb0125","first-page":"139","article-title":"Drug-coated balloon versus plain old balloon angioplasty in femoropopliteal disease: an updated meta-analysis of randomized controlled trials","volume":"94","author":"Anantha-Narayanan","year":"2019","journal-title":"Catheter Cardiovasc Interv"},{"issue":"6","key":"10.1016\/j.carrev.2020.03.030_bb0130","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1161\/CIRCULATIONAHA.113.001811","article-title":"Drug-eluting balloon in peripheral intervention for below the knee angioplasty evaluation (DEBATE-BTK): a randomized trial in diabetic patients with critical limb ischemia","volume":"128","author":"Liistro","year":"2013","journal-title":"Circulation."},{"issue":"2","key":"10.1016\/j.carrev.2020.03.030_bb0135","first-page":"207","article-title":"The \u201cDEBELLUM\u201d--lower limb multilevel treatment with drug eluting balloon--randomized trial: 1-year results","volume":"55","author":"Fanelli","year":"2014","journal-title":"J Cardiovasc Surg (Torino)"},{"issue":"24","key":"10.1016\/j.carrev.2020.03.030_bb0140","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.011245","article-title":"Risk of death following application of paclitaxel-coated balloons and stents in the Femoropopliteal artery of the leg: a systematic review and meta-analysis of randomized controlled trials","volume":"7","author":"Katsanos","year":"2018","journal-title":"J Am Heart Assoc"},{"issue":"4","key":"10.1016\/j.carrev.2020.03.030_bb0145","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1001\/jamacardio.2019.0325","article-title":"Association of Survival With Femoropopliteal Artery Revascularization With Drug-Coated Devices","volume":"4","author":"Secemsky","year":"2019","journal-title":"JAMA Cardiol"},{"issue":"12","key":"10.1016\/j.carrev.2020.03.030_bb0150","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1016\/j.jcin.2015.07.011","volume":"8","author":"Zeller","year":"2015","journal-title":"JACC Cardiovasc Interv"},{"issue":"4","key":"10.1016\/j.carrev.2020.03.030_bb0155","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1177\/1358863X18775593","article-title":"Adjunctive stent use during endovascular intervention to the femoropopliteal artery with drug coated balloons: insights from the XLPAD registry","volume":"23","author":"Kokkinidis","year":"2018","journal-title":"Vasc Med"},{"issue":"1","key":"10.1016\/j.carrev.2020.03.030_bb0160","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/nrcardio.2013.165","article-title":"Drug-coated balloon therapy in coronary and peripheral artery disease","volume":"11","author":"Byrne","year":"2014","journal-title":"Nat Rev Cardiol"},{"issue":"9","key":"10.1016\/j.carrev.2020.03.030_bb0165","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1177\/0003319715626849","article-title":"Low rates of revascularization and high in-hospital mortality in patients with ischemic lower limb amputation: morbidity and mortality of ischemic amputation","volume":"67","author":"Malyar","year":"2016","journal-title":"Angiology."},{"issue":"1","key":"10.1016\/j.carrev.2020.03.030_bb0170","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1161\/CIRCOUTCOMES.108.775247","article-title":"One-year costs in patients with a history of or at risk for atherothrombosis in the United States","volume":"1","author":"Mahoney","year":"2008","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"3","key":"10.1016\/j.carrev.2020.03.030_bb0175","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1177\/1358863X08089277","article-title":"National health care costs of peripheral arterial disease in the Medicare population","volume":"13","author":"Hirsch","year":"2008","journal-title":"Vasc Med"},{"issue":"2","key":"10.1016\/j.carrev.2020.03.030_bb0180","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1001\/jama.295.2.180","article-title":"International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis","volume":"295","author":"Bhatt","year":"2006","journal-title":"Jama."},{"key":"10.1016\/j.carrev.2020.03.030_bb0185","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.atherosclerosis.2019.09.012","article-title":"Morbidity and mortality associated with atherosclerotic peripheral artery disease: a systematic review","volume":"293","author":"Agnelli","year":"2020","journal-title":"Atherosclerosis."},{"key":"10.1016\/j.carrev.2020.03.030_bb0190","first-page":"417","article-title":"Lower extremity amputation in peripheral artery disease: improving patient outcomes","volume":"10","author":"Swaminathan","year":"2014","journal-title":"Vasc Health Risk Manag"},{"issue":"16","key":"10.1016\/j.carrev.2020.03.030_bb0195","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.009724","article-title":"Determinants of long-term outcomes and costs in the Management of Critical Limb Ischemia: a population-based cohort study","volume":"7","author":"Mustapha","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.carrev.2020.03.030_bb0200","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.avsg.2018.03.011","article-title":"Nationally representative readmission factors in patients with claudication and critical limb ischemia","volume":"52","author":"Martinez","year":"2018","journal-title":"Ann Vasc Surg"},{"key":"10.1016\/j.carrev.2020.03.030_bb0205","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.2147\/CIA.S137570","article-title":"Mortality after major amputation in elderly patients with critical limb ischemia","volume":"12","author":"Klaphake","year":"2017","journal-title":"Clin Interv Aging"},{"issue":"4","key":"10.1016\/j.carrev.2020.03.030_bb0210","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.ejvs.2017.07.005","article-title":"Amputation rates, mortality, and pre-operative comorbidities in patients Revascularised for intermittent claudication or critical limb Ischaemia: a population based study","volume":"54","author":"Baubeta Fridh","year":"2017","journal-title":"European journal of vascular and endovascular surgery: the official journal of the European Society for Vascular Surgery."},{"issue":"16","key":"10.1016\/j.carrev.2020.03.030_bb0215","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1016\/j.jacc.2016.02.040","article-title":"Nationwide trends of hospital admission and outcomes among critical limb ischemia patients: from 2003-2011","volume":"67","author":"Agarwal","year":"2016","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.carrev.2020.03.030_bb0220","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1177\/1526602819827295","article-title":"One-year results of the LIBERTY 360 study: evaluation of acute and midterm clinical outcomes of peripheral endovascular device interventions","volume":"26","author":"Mustapha","year":"2019","journal-title":"Journal of endovascular therapy: an official journal of the International Society of Endovascular Specialists"},{"key":"10.1016\/j.carrev.2020.03.030_bb0225","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.ahj.2015.12.013","article-title":"The LIBERTY study: design of a prospective, observational, multicenter trial to evaluate the acute and long-term clinical and economic outcomes of real-world endovascular device interventions in treating peripheral artery disease","volume":"174","author":"Adams","year":"2016","journal-title":"Am Heart J"},{"issue":"6s","key":"10.1016\/j.carrev.2020.03.030_bb0230","article-title":"Global vascular guidelines on the management of chronic limb-threatening ischemia","volume":"69","author":"Conte","year":"2019","journal-title":"Journal of vascular surgery"},{"issue":"6s","key":"10.1016\/j.carrev.2020.03.030_bb0235","article-title":"Global vascular guidelines on the management of chronic limb-threatening ischemia","volume":"69","author":"Conte","year":"2019","journal-title":"Journal of vascular surgery"},{"issue":"1","key":"10.1016\/j.carrev.2020.03.030_bb0240","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1177\/1526602814565778","article-title":"Commentary: treatment of in-stent restenosis in the superficial femoral artery: at the crossroads of using either covered stents or paclitaxel-based modalities","volume":"22","author":"Truijers","year":"2015","journal-title":"Journal of endovascular therapy: an official journal of the International Society of Endovascular Specialists."},{"issue":"18","key":"10.1016\/j.carrev.2020.03.030_bb0245","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1056\/NEJMoa051303","article-title":"Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery","volume":"354","author":"Schillinger","year":"2006","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.carrev.2020.03.030_bb0250","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1161\/CIRCULATIONAHA.107.689141","article-title":"Nitinol stent implantation versus percutaneous transluminal angioplasty in superficial femoral artery lesions up to 10 cm in length: the femoral artery stenting trial (FAST)","volume":"116","author":"Krankenberg","year":"2007","journal-title":"Circulation."},{"issue":"24","key":"10.1016\/j.carrev.2020.03.030_bb0255","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1016\/j.jacc.2013.03.034","article-title":"Sustained safety and effectiveness of paclitaxel-eluting stents for femoropopliteal lesions: 2-year follow-up from the Zilver PTX randomized and single-arm clinical studies","volume":"61","author":"Dake","year":"2013","journal-title":"J Am Coll Cardiol"},{"issue":"15","key":"10.1016\/j.carrev.2020.03.030_bb0260","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1016\/j.jacc.2013.05.079","volume":"62","author":"Lammer","year":"2013","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.carrev.2020.03.030_bb0265","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jcin.2013.05.022","article-title":"The LEVANT I (Lutonix paclitaxel-coated balloon for the prevention of femoropopliteal restenosis) trial for femoropopliteal revascularization: first-in-human randomized trial of low-dose drug-coated balloon versus uncoated balloon angioplasty","volume":"7","author":"Scheinert","year":"2014","journal-title":"JACC Cardiovasc Interv"},{"issue":"2","key":"10.1016\/j.carrev.2020.03.030_bb0270","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1056\/NEJMoa1406235","article-title":"Trial of a paclitaxel-coated balloon for Femoropopliteal artery disease","volume":"373","author":"Rosenfield","year":"2015","journal-title":"N Engl J Med"},{"issue":"21","key":"10.1016\/j.carrev.2020.03.030_bb0275","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1016\/j.jacc.2015.09.063","article-title":"Durability of treatment effect using a drug-coated balloon for Femoropopliteal lesions: 24-month results of IN.PACT SFA","volume":"66","author":"Laird","year":"2015","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.carrev.2020.03.030_bb0280","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ejvs.2018.12.020","article-title":"Restenosis prevention with drug eluting or covered stents in femoropopliteal arterial occlusive disease: evidence from a comprehensive network meta-analysis","volume":"58","author":"He","year":"2019","journal-title":"European journal of vascular and endovascular surgery: the official journal of the European Society for Vascular Surgery"},{"issue":"1","key":"10.1016\/j.carrev.2020.03.030_bb0285","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1177\/1526602818823557","article-title":"One-year clinical outcomes of the Legflow drug-coated balloon for the treatment of Femoropopliteal occlusions registry","volume":"26","author":"Stabile","year":"2019","journal-title":"Journal of endovascular therapy: an official journal of the International Society of Endovascular Specialists."},{"issue":"8","key":"10.1016\/j.carrev.2020.03.030_bb0290","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/j.avsg.2013.01.010","article-title":"Systematic review on health-related quality of life after revascularization and primary amputation in patients with critical limb ischemia","volume":"27","author":"Bosma","year":"2013","journal-title":"Ann Vasc Surg"},{"issue":"3","key":"10.1016\/j.carrev.2020.03.030_bb0295","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1161\/CIRCULATIONAHA.115.018035","article-title":"Endovascular therapy for Femoropopliteal disease: drug-eluting stents are not the default therapy","volume":"133","author":"Garcia","year":"2016","journal-title":"Circulation."},{"issue":"3","key":"10.1016\/j.carrev.2020.03.030_bb0300","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1177\/1526602819839044","article-title":"Outcomes after drug-coated balloon treatment of Femoropopliteal lesions in patients with critical limb ischemia: a post hoc analysis from the IN.PACT global study","volume":"26","author":"Reijnen","year":"2019","journal-title":"Journal of endovascular therapy: an official journal of the International Society of Endovascular Specialists."},{"key":"10.1016\/j.carrev.2020.03.030_bb0305","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1007\/s00270-019-02279-6","article-title":"Drug-coated balloon angioplasty of Infrapopliteal lesions in patients with critical limb Ischaemia: 1-year results of the APOLLO trial","volume":"42","author":"Teichgraber","year":"2019","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.carrev.2020.03.030_bb0310","series-title":"Carnevale M","author":"Phair","year":"2019"},{"issue":"4","key":"10.1016\/j.carrev.2020.03.030_bb0315","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.carrev.2012.04.007","article-title":"Combined treatment of heavy calcified femoro-popliteal lesions using directional atherectomy and a paclitaxel coated balloon: one-year single Centre clinical results","volume":"13","author":"Cioppa","year":"2012","journal-title":"Cardiovasc Revasc Med"},{"issue":"5","key":"10.1016\/j.carrev.2020.03.030_bb0320","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1177\/1538574416647500","article-title":"The mid-term clinical follow-up using drug-eluting balloons on Tibial artery \u201cDe novo\u201d lesions in patients with critical limb ischemia: a cohort study","volume":"50","author":"Tolva","year":"2016","journal-title":"Vasc Endovascular Surg"},{"issue":"4","key":"10.1016\/j.carrev.2020.03.030_bb0325","doi-asserted-by":"crossref","first-page":"94","DOI":"10.5758\/vsi.2018.34.4.94","article-title":"Prognostic factors in patients treated with drug-coated balloon angioplasty for symptomatic peripheral artery disease","volume":"34","author":"Sigala","year":"2018","journal-title":"Vasc Specialist Int"},{"issue":"1","key":"10.1016\/j.carrev.2020.03.030_bb0330","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/joic.12355","article-title":"Drug-eluting balloon angioplasty for below the knee lesions in end stage renal disease patients with critical limb ischemia: midterm results","volume":"30","author":"Teymen","year":"2017","journal-title":"J Interv Cardiol"},{"issue":"3","key":"10.1016\/j.carrev.2020.03.030_bb0335","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1177\/1526602816645080","article-title":"Single-center experience with Lutonix drug-coated balloons in Infrapopliteal arteries","volume":"23","author":"Steiner","year":"2016","journal-title":"Journal of endovascular therapy: an official journal of the International Society of Endovascular Specialists."},{"issue":"1 Pt B","key":"10.1016\/j.carrev.2020.03.030_bb0340","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.carrev.2017.06.006","article-title":"Drug-coated balloon angioplasty for the management of recurring infrapopliteal disease in diabetic patients with critical limb ischemia","volume":"19","author":"Palena","year":"2018","journal-title":"Cardiovasc Revasc Med."},{"issue":"6","key":"10.1016\/j.carrev.2020.03.030_bb0345","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1583\/13-4308MR.1","article-title":"Treatment of chronic SFA in-stent occlusion with combined laser atherectomy and drug-eluting balloon angioplasty in patients with critical limb ischemia: a single-center, prospective, randomized study","volume":"20","author":"Gandini","year":"2013","journal-title":"Journal of endovascular therapy: an official journal of the International Society of Endovascular Specialists."},{"issue":"6","key":"10.1016\/j.carrev.2020.03.030_bb0350","first-page":"1078","article-title":"Mid-term outcomes of orbital atherectomy combined with drug-coated balloon angioplasty for treatment of femoropopliteal disease","volume":"89","author":"Foley","year":"2017","journal-title":"Catheter Cardiovasc Interv"},{"issue":"15","key":"10.1016\/j.carrev.2020.03.030_bb0355","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1016\/j.jacc.2014.06.1198","article-title":"Drug-eluting balloon versus standard balloon angioplasty for infrapopliteal arterial revascularization in critical limb ischemia: 12-month results from the IN.PACT DEEP randomized trial","volume":"64","author":"Zeller","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.carrev.2020.03.030_bb0360","doi-asserted-by":"crossref","first-page":"31","DOI":"10.4103\/jcis.JCIS_34_17","article-title":"One year primary patency of Infrapopliteal angioplasty using drug- eluting balloons: single center experience at king Hussein medical center","volume":"7","author":"Haddad","year":"2017","journal-title":"J Clin Imaging Sci"},{"issue":"13","key":"10.1016\/j.carrev.2020.03.030_bb0365","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1161\/CIRCULATIONAHA.107.735985","article-title":"Inhibition of restenosis in femoropopliteal arteries: paclitaxel-coated versus uncoated balloon: femoral paclitaxel randomized pilot trial","volume":"118","author":"Werk","year":"2008","journal-title":"Circulation."},{"issue":"5","key":"10.1016\/j.carrev.2020.03.030_bb0370","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1161\/CIRCULATIONAHA.114.011004","article-title":"Drug-coated balloon versus standard percutaneous transluminal angioplasty for the treatment of superficial femoral and popliteal peripheral artery disease: 12-month results from the IN.PACT SFA randomized trial","volume":"131","author":"Tepe","year":"2015","journal-title":"Circulation."},{"issue":"6","key":"10.1016\/j.carrev.2020.03.030_bb0375","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1161\/CIRCINTERVENTIONS.112.971630","article-title":"Paclitaxel-coated balloons reduce restenosis after femoro-popliteal angioplasty: evidence from the randomized PACIFIER trial","volume":"5","author":"Werk","year":"2012","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2020.03.030_bb0380","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.ijsu.2016.09.014","article-title":"Drug-eluting balloon versus standard percutaneous transluminal angioplasty in infrapopliteal arterial disease: a meta-analysis of randomized trials","volume":"35","author":"Wu","year":"2016","journal-title":"Int J Surg"},{"issue":"1","key":"10.1016\/j.carrev.2020.03.030_bb0385","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1148\/radiol.2211010039","article-title":"Balloon dilation and stent implantation for treatment of femoropopliteal arterial disease: meta-analysis","volume":"221","author":"Muradin","year":"2001","journal-title":"Radiology."},{"issue":"7","key":"10.1016\/j.carrev.2020.03.030_bb0390","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.jacc.2013.09.073","article-title":"Association between statin medications and mortality, major adverse cardiovascular event, and amputation-free survival in patients with critical limb ischemia","volume":"63","author":"Westin","year":"2014","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.carrev.2020.03.030_bb0395","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.jvs.2009.08.073","article-title":"Critical limb ischemia","volume":"51","author":"Varu","year":"2010","journal-title":"J Vasc Surg"},{"issue":"4","key":"10.1016\/j.carrev.2020.03.030_bb0400","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1007\/s00270-008-9331-7","article-title":"Subintimal angioplasty for peripheral arterial occlusive disease: a systematic review","volume":"31","author":"Met","year":"2008","journal-title":"Cardiovasc Intervent Radiol"},{"issue":"5","key":"10.1016\/j.carrev.2020.03.030_bb0405","first-page":"701","article-title":"Clinical follow-up in endovascular treatment for TASC C-D lesions in femoro-popliteal segment","volume":"73","author":"Rabellino","year":"2009","journal-title":"Catheter Cardiovasc Interv"},{"issue":"7","key":"10.1016\/j.carrev.2020.03.030_bb0410","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.jcin.2014.01.168","article-title":"Shared and differential factors influencing restenosis following endovascular therapy between TASC (trans-Atlantic inter-society consensus) II class a to C and D lesions in the femoropopliteal artery","volume":"7","author":"Iida","year":"2014","journal-title":"JACC Cardiovasc Interv"},{"issue":"5","key":"10.1016\/j.carrev.2020.03.030_bb0415","doi-asserted-by":"crossref","DOI":"10.1016\/j.jvs.2013.02.252","article-title":"Current efficacy of open and endovascular interventions for advanced superficial femoral artery occlusive disease","volume":"58","author":"Smolock","year":"2013","journal-title":"Journal of vascular surgery"},{"issue":"6","key":"10.1016\/j.carrev.2020.03.030_bb0420","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1016\/j.jvs.2010.01.062","article-title":"Endovascular interventions for TASC II D femoropopliteal lesions","volume":"51","author":"Baril","year":"2010","journal-title":"J Vasc Surg"},{"issue":"3","key":"10.1016\/j.carrev.2020.03.030_bb0425","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1177\/1526602817705135","article-title":"Major limb outcomes following lower extremity endovascular revascularization in patients with and without diabetes mellitus","volume":"24","author":"Shammas","year":"2017","journal-title":"Journal of endovascular therapy: an official journal of the International Society of Endovascular Specialists."},{"issue":"4","key":"10.1016\/j.carrev.2020.03.030_bb0430","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1177\/1358863X17714153","article-title":"Long-term outcomes in patients with critical limb ischemia and heart failure with preserved or reduced ejection fraction","volume":"22","author":"Khaira","year":"2017","journal-title":"Vasc Med"},{"issue":"12","key":"10.1016\/j.carrev.2020.03.030_bb0435","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1016\/j.jcin.2014.06.018","article-title":"Two-year life expectancy in patients with critical limb ischemia","volume":"7","author":"Soga","year":"2014","journal-title":"JACC Cardiovasc Interv"},{"issue":"6","key":"10.1016\/j.carrev.2020.03.030_bb0440","doi-asserted-by":"crossref","DOI":"10.1016\/j.jvs.2009.09.044","article-title":"Suggested objective performance goals and clinical trial design for evaluating catheter-based treatment of critical limb ischemia","volume":"50","author":"Conte","year":"2009","journal-title":"Journal of vascular surgery"}],"container-title":["Cardiovascular Revascularization Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1553838920301640?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1553838920301640?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:18:19Z","timestamp":1761560299000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1553838920301640"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":88,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["S1553838920301640"],"URL":"https:\/\/doi.org\/10.1016\/j.carrev.2020.03.030","relation":{},"ISSN":["1553-8389"],"issn-type":[{"value":"1553-8389","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparative 12-Month Outcomes of Drug-Coated Balloon Versus Non-Drug-Coated Balloon Revascularization Strategy in Chronic Limb-Threatening Ischemia: Results From the XLPAD Registry","name":"articletitle","label":"Article Title"},{"value":"Cardiovascular Revascularization Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.carrev.2020.03.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}